Blood‐Brain Barrier Abnormalities in Alzheimer's Diseasea
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
We studied the cerebral microcirculation and the blood-brain barrier in Alzheimer's disease by assessing the glucose transporter, several functionally important enzymes, and adrenergic receptors in isolated brain microvessels that were obtained at autopsy from subjects with Alzheimer's disease and from age-matched controls. We found a marked decrease of about 50% in the density of the glucose transporter, but increased densities of beta 2- and alpha 2-adrenergic receptors in cerebral microvessels obtained from subjects with Alzheimer's disease. The biologic implications of these findings are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454
Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer Disease
Kalaria, R. N., & Harik, S. I. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07399.x · Cited by 338
Self-citation
Cited by
Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease
Erickson, M. A., & Banks, W. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.135 · Cited by 572
Friedman, A., Kaufer, D., Shemer, J., Hendler, I., Soreq, H., & Tur-Kaspa, I. (1996) · Nature Medicine · doi:10.1038/nm1296-1382 · Cited by 360
Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
Chew, H., Solomon, V. A., & Fonteh, A. N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00598 · Cited by 353
“Studies have also indicated that AD pathology includes reduced expression of glucose transporters in the BBB (Kalaria and Harik, 1989; Harik and Kalaria, 1991; Guo et al., 2005; Agrawal et al., 2017; Block, 2019).”
BackgroundGlucose Transporters in Brain: In Health and in Alzheimer’s Disease
Szablewski, L. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160841 · Cited by 211
A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease
Kyrtata, N., Emsley, H. C. A., Sparasci, O., Parkes, L. M., & Dickie, B. R. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.626636 · Cited by 171
Metadata
- Authors
- HARIK, S. I., & KALARIA, R. N.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 1991-12
- Volume
- 640
- Issue
- 1
- Pages
- 47-52
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2463127778
- Cited by
- 35
- References
- 2
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood‐Brain Barrier Abnormalities in Alzheimer's Diseasea. https://app.cochat.ai/papers/10.1111/j.1749-6632.1991.tb00189.x
- The paper
- HARIK, S. I., & KALARIA, R. N. (1991). Blood‐Brain Barrier Abnormalities in Alzheimer's Diseasea. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1991.tb00189.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.